格隆汇1月6日丨Alterity Therapeutics(ATHE.US)盘前大涨近40%,报1.16美元,此前公司获得治疗神经退行性疾病的药物专利。 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-048719 Act: 34 Size: 37 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-046502 Act: 34 Size: 2 MB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-046500 Act: 34 Size: 209 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-046498 Act: 34 Size: 42 KB 网页链接
$Alterity医疗(ATHE)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-21-046254 Act: 34 Size: 10 MB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-040201 Act: 34 Size: 49 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-039399 Act: 34 Size: 134 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-035651 Act: 34 Size: 26 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-035390 Act: 34 Size: 60 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-035186 Act: 34 Size: 36 KB 网页链接